Netakimab — new IL-17а inhibitor: 12-week results of phase III clinical study BCD-085-7/PLANETA in patients with moderate-tosevere plaque psoriasis - PDF (Russian)


Copyright (c)



This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies